ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

MSKCC In Outreach Agreement With Phelps

December 1, 1995

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Funding Opportunities

October 25, 2002

Statin Drugs May Prevent Breast Cancer, Lab Suggests

April 25, 2003